A Texas State University microbiology and virology specialist outlined key concerns surrounding the ongoing Ebola outbreak in the Democratic Republic of Congo and Uganda, which involves the rare Bundibugyo strain of the virus. Unlike more common Ebola strains, Bundibugyo currently has no approved vaccine or targeted treatment, complicating containment efforts as cases and deaths continue to rise. Experts warn that armed conflict, weak healthcare infrastructure, population displacement, and cross-border movement are accelerating the spread of the outbreak. While the immediate risk to the United States remains low, public health officials emphasize the importance of preparedness, global surveillance, laboratory readiness, and international cooperation. The article also highlights the biology of Ebola virus disease, how it spreads through direct contact with infected bodily fluids, and the critical role of early detection, supportive care, and public trust in science during outbreak response efforts. Read full story at the Texas State University
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.